ProMedTours > MEDICAL NEWS
 

Medical News

Montelukast Warning Upgraded

]]>(MedPage Today) -- WASHINGTON -- Concerned about "continued reports of suicide" and other neuropsychiatric events among users of the allergy and asthma drug montelukast (Singulair), the FDA is moving previous warnings about these risks into a...

Diet Drug Yanked Over Cancer Risk

]]>(MedPage Today) -- WASHINGTON -- The FDA called for a voluntarily recall of the weight management drug lorcaserin (Belviq, Belviq XR) after data from a postmarketing trial suggested increased cancer risk with the agent. Manufacturer Eisai will...

Diet Drug Possibly Linked to Cancer, FDA Says

]]>(MedPage Today) -- Post-marketing study data on the weight management drug lorcaserin (Belviq, Belviq XR) showed an increase in cancer risk, the FDA cautioned. The drug safety communication warned that the mechanism isn't clear and it's not certain...

J&J Pulls Baby Powder From Market

]]>(MedPage Today) -- WASHINGTON -- Johnson & Johnson is recalling one lot of its famous baby powder because of possible asbestos contamination, the FDA announced Friday. "FDA testing has found that a sample from one lot of the product contains...

FDA OKs First Tx for Rare Disease That Makes Light Painful

]]>(MedPage Today) -- The FDA approved the first treatment, afamelanotide (Scenesse), for rare phototoxic disorder erythropoietic protoporphyria. Afemelanotide, an melanocortin-1 receptor agonist, is indicated to increase pain-free light exposure...

The FDA Database Where a Death Isn't a 'Death'

]]>(MedPage Today) -- Many patient deaths may go uncounted by taking the FDA's Manufacturer and User Facility Device Experience (MAUDE) database at face value, researchers found. A close look at the publicly available postmarketing medical device...

Canagliflozin OK'd for Preventing HF Hospitalization in T2D

]]>(MedPage Today) -- WASHINGTON -- In another label expansion, the FDA approved new cardiovascular and renal prevention indications for canagliflozin (Invokana), according to a statement from the Janssen unit of Johnson & Johnson. The SGLT...

Zantac Generic Pulled From Markets Worldwide

]]>(MedPage Today) -- One manufacturer of generic ranitidine (Zantac), Novartis's Sandoz unit, has reportedly decided to halt distribution of the antacid drug until a contamination issue is resolved. Last week, the FDA said some lots of ranitidine...

FDA: Nitrosamines Found in New Class of Meds

]]>(MedPage Today) -- WASHINGTON -- Some lots of the antacid drug ranitidine (Zantac) were found to contain small amounts of N-nitrosodimethylamine (NDMA), the FDA said Friday morning. NDMA is one of the potentially carcinogenic chemicals that...

Second-Hand Vaping; PTSD and Ovarian Cancer; Un-Real-World Cancer Studies?

]]>(MedPage Today) -- One third of middle- and high-school students reported exposure to second-hand vaping aerosol in public places. (CNN) AbbVie will discontinue development of rovalpituzumab tesirine (Rova-T) after a phase III clinical trial failed...